These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 19408305

  • 1. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Vivas-Mejía PE, Ozpolat B, Chen X, Lopez-Berestein G.
    Int J Cancer; 2009 Jul 15; 125(2):264-75. PubMed ID: 19408305
    [Abstract] [Full Text] [Related]

  • 2. Peroxiredoxin 3 Has Important Roles on Arsenic Trioxide Induced Apoptosis in Human Acute Promyelocytic Leukemia Cell Line via Hyperoxidation of Mitochondrial Specific Reactive Oxygen Species.
    Mun YC, Ahn JY, Yoo ES, Lee KE, Nam EM, Huh J, Woo HA, Rhee SG, Seong CM.
    Mol Cells; 2020 Sep 30; 43(9):813-820. PubMed ID: 32975211
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R, Xia L, Gabrilove J, Waxman S, Jing Y.
    Leukemia; 2013 Feb 30; 27(2):315-24. PubMed ID: 22751450
    [Abstract] [Full Text] [Related]

  • 4. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Ozpolat B, Akar U, Zorrilla-Calancha I, Vivas-Mejia P, Acevedo-Alvarez M, Lopez-Berestein G.
    Apoptosis; 2008 Jul 30; 13(7):915-28. PubMed ID: 18491231
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS, Kfoury Y, Darwiche N, Panjarian S, Kozhaya L, Nasr R, Abdallah M, Hermine O, El-Sabban M, de Thé H, Bazarbachi A.
    Haematologica; 2007 Jun 30; 92(6):753-62. PubMed ID: 17550847
    [Abstract] [Full Text] [Related]

  • 6. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
    Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A, Alimoghaddam K.
    Tumour Biol; 2012 Feb 30; 33(1):157-72. PubMed ID: 22072212
    [Abstract] [Full Text] [Related]

  • 7. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH.
    Leuk Res; 2014 Aug 30; 38(8):977-82. PubMed ID: 24953245
    [Abstract] [Full Text] [Related]

  • 8. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
    Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z.
    Blood; 1996 Aug 01; 88(3):1052-61. PubMed ID: 8704214
    [Abstract] [Full Text] [Related]

  • 9. Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).
    Hassani S, Khaleghian A, Ahmadian S, Alizadeh S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.
    Ann Hematol; 2018 Jan 01; 97(1):83-93. PubMed ID: 29159499
    [Abstract] [Full Text] [Related]

  • 10. Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.
    Yaghmaie M, Mozdarani H, Alimoghaddam K, Ghaffari SH, Ghavamzadeh A, Hajhashemi M.
    Med Oncol; 2012 Jun 01; 29(2):1209-16. PubMed ID: 21544632
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
    Ghaffari SH, Momeny M, Bashash D, Mirzaei R, Ghavamzadeh A, Alimoghaddam K.
    Hematology; 2012 Jul 01; 17(4):198-206. PubMed ID: 22944098
    [Abstract] [Full Text] [Related]

  • 12. Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.
    Zaki Dizaji M, Ghaffari SH, Hosseini E, Alizadeh N, Rostami S, Momeny M, Alimoghaddam K, Ghavamzadeh A.
    Asia Pac J Clin Oncol; 2017 Apr 01; 13(2):e21-e30. PubMed ID: 27770503
    [Abstract] [Full Text] [Related]

  • 13. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y.
    Clin Cancer Res; 2012 Dec 15; 18(24):6690-701. PubMed ID: 23082001
    [Abstract] [Full Text] [Related]

  • 14. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells.
    Jo S, Lee YL, Kim S, Lee H, Chung H.
    Biochim Biophys Acta; 2016 Jul 15; 1863(7 Pt A):1499-509. PubMed ID: 27030546
    [Abstract] [Full Text] [Related]

  • 15. Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.
    Song LL, Tu YY, Xia L, Wang WW, Wei W, Ma CM, Wen DH, Lei H, Xu HZ, Wu YL.
    PLoS One; 2014 Jul 15; 9(8):e104985. PubMed ID: 25115845
    [Abstract] [Full Text] [Related]

  • 16. Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
    Sahara N, Takeshita A, Kobayashi M, Shigeno K, Nakamura S, Shinjo K, Naito K, Maekawa M, Horii T, Ohnishi K, Kitamura K, Naoe T, Hayash H, Ohno R.
    Leuk Lymphoma; 2004 May 15; 45(5):987-95. PubMed ID: 15291359
    [Abstract] [Full Text] [Related]

  • 17. Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis.
    Pan C, Zhu D, Zhuo J, Li L, Wang D, Zhang CY, Liu Y, Zen K.
    Sci Rep; 2016 Mar 24; 6():23710. PubMed ID: 27010069
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ.
    Leukemia; 2000 Feb 24; 14(2):262-70. PubMed ID: 10673743
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y, Hu X, Hou K, Liu Y.
    Cancer Lett; 2009 Nov 01; 284(2):208-15. PubMed ID: 19457607
    [Abstract] [Full Text] [Related]

  • 20. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
    Dunoyer-Geindre S, Rivier-Cordey AS, Tsopra O, Lecompte T, Kruithof EKO.
    Ann Hematol; 2017 Jun 01; 96(6):905-917. PubMed ID: 28343272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.